Concepedia

Hassana el Haddaoui

HE

2

Publications

23

Citations

2

H-Index

2022

Active since

Affiliations

Erasmus MC Cancer Institute(Current)

Hassana el Haddaoui is an author at Erasmus MC Cancer Institute specializing in tumor immunity, medicine, and immune regulation.

ORCID

Top concepts

Publications per year

2022–2024

2

Publications

2

Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program

Hassana el Haddaoui, Rianne Brood, Diba Latifi et al. · Cancers · 2022 · 12 citations · Full text

, , +21

Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses

Casper W.F. van Eijck, Hassana el Haddaoui, Songul Kucukcelebi et al. · Clinical Cancer Research · 2024 · 11 citations · Full text

Rows per page

1–2 of 2